This article needs additional citations for verification. Please help improve this articlebyadding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Ceftizoxime" – news · newspapers · books · scholar · JSTOR (April 2013) (Learn how and when to remove this message) |
![]() | |
Clinical data | |
---|---|
Trade names | Cefizox |
AHFS/Drugs.com | Consumer Drug Information |
MedlinePlus | a684043 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.210.846 ![]() |
Chemical and physical data | |
Formula | C13H13N5O5S2 |
Molar mass | 383.40 g·mol−1 |
Ceftizoxime is a third-generation cephalosporin available for parenteral administration.[1] Unlike other third-generation cephalosporins, the whole C-3 side chain in ceftizoxime has been removed to prevent deactivationbyhydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subject to metabolism. It was removed from the US Market in 2007.
Injectable third generation cephalosporin antibiotic related to cefotaxime, q.v. Exhibits broad spectrum activity and resistance to β-lactamase hydrolysis.
![]() | This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |